Dear esteemed National Delegates,

It is my pleasure to provide you attached with the EANM procedure guidelines for radionuclide therapy with 177Lu-labeled PSMA-ligands (177Lu-PSMA-RLT) written under the lead of the EANM Oncology & Theranostics Committee.

As part of the EANM guideline review process, I kindly invite you to share this draft within your national society as appropriate and get back to me with your society’s collected comments, if any, by April 26, 2019at the latest.

Logg inn for å se vedlegget.